Real-world use of adjuvant nivolumab among patients with esophageal and gastroesophageal junction cancer at a large integrated health system. - Gochi AM; Jeffs S; Hung YY; Yang J; Wang T; Okano G; Rosenblatt L; Villacorta R; Velotta JB (JTCVS open, 2025)